TY - JOUR T1 - Treatment options for apnoea of prematurity JF - Archives of Disease in Childhood - Fetal and Neonatal Edition JO - Arch Dis Child Fetal Neonatal Ed SP - F352 LP - F356 DO - 10.1136/archdischild-2015-310228 VL - 101 IS - 4 AU - Sarah U Morton AU - Vincent C Smith Y1 - 2016/07/01 UR - http://fn.bmj.com/content/101/4/F352.abstract N2 - Apnoea of prematurity (AOP) affects almost all infants born at <28 weeks gestation or with birth weight <1000 g. When untreated, AOP may be associated with negative outcomes. Because of these negative outcomes, effective treatment for AOP is an important part of optimising care of preterm infants. Standard treatment usually involves xanthine therapy and respiratory support. Cutting-edge work with stochastic vibrotactile stimulation and new pharmaceutical agents continues to expand therapeutic options. In this article, we review the pathophysiology of AOP, associated conditions and treatment options. ER -